InVivo Therapeutics Holdings Overview

InVivo Therapeutics Holdings EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NVIV.

Quarterly EBIT

-$2.77M

↑ 1.11% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$9.80M

↑ 11.8% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin